COLB vs. BMY
Compare and contrast key facts about Columbia Banking System, Inc. (COLB) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: COLB or BMY.
Correlation
The correlation between COLB and BMY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
COLB vs. BMY - Performance Comparison
Key characteristics
COLB:
0.24
BMY:
0.64
COLB:
0.62
BMY:
1.21
COLB:
1.09
BMY:
1.15
COLB:
0.18
BMY:
0.38
COLB:
0.51
BMY:
1.57
COLB:
20.04%
BMY:
11.56%
COLB:
42.12%
BMY:
28.50%
COLB:
-85.93%
BMY:
-70.62%
COLB:
-31.55%
BMY:
-23.12%
Fundamentals
COLB:
$6.00B
BMY:
$116.92B
COLB:
$2.32
BMY:
-$3.58
COLB:
2.26
BMY:
1.92
COLB:
$2.93B
BMY:
$47.44B
COLB:
$2.84B
BMY:
$33.40B
COLB:
$720.05M
BMY:
$5.06B
Returns By Period
In the year-to-date period, COLB achieves a 8.77% return, which is significantly lower than BMY's 17.38% return. Over the past 10 years, COLB has outperformed BMY with an annualized return of 5.03%, while BMY has yielded a comparatively lower 2.84% annualized return.
COLB
8.77%
-8.26%
51.53%
9.10%
-1.87%
5.03%
BMY
17.38%
-0.95%
40.36%
17.50%
1.50%
2.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
COLB vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Columbia Banking System, Inc. (COLB) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
COLB vs. BMY - Dividend Comparison
COLB's dividend yield for the trailing twelve months is around 5.30%, more than BMY's 4.19% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLB Columbia Banking System, Inc. | 5.30% | 5.96% | 6.77% | 6.05% | 5.49% | 3.96% | 3.14% | 2.03% | 3.42% | 4.68% | 3.40% | 1.49% |
BMY Bristol-Myers Squibb Company | 4.19% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Drawdowns
COLB vs. BMY - Drawdown Comparison
The maximum COLB drawdown since its inception was -85.93%, which is greater than BMY's maximum drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for COLB and BMY. For additional features, visit the drawdowns tool.
Volatility
COLB vs. BMY - Volatility Comparison
Columbia Banking System, Inc. (COLB) has a higher volatility of 9.98% compared to Bristol-Myers Squibb Company (BMY) at 6.16%. This indicates that COLB's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
COLB vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Columbia Banking System, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities